|
WO2012129363A2
(en)
|
2011-03-24 |
2012-09-27 |
President And Fellows Of Harvard College |
Single cell nucleic acid detection and analysis
|
|
US9892230B2
(en)
|
2012-03-08 |
2018-02-13 |
The Chinese University Of Hong Kong |
Size-based analysis of fetal or tumor DNA fraction in plasma
|
|
US11261494B2
(en)
|
2012-06-21 |
2022-03-01 |
The Chinese University Of Hong Kong |
Method of measuring a fractional concentration of tumor DNA
|
|
US11913065B2
(en)
|
2012-09-04 |
2024-02-27 |
Guardent Health, Inc. |
Systems and methods to detect rare mutations and copy number variation
|
|
DE202013012824U1
(de)
|
2012-09-04 |
2020-03-10 |
Guardant Health, Inc. |
Systeme zum Erfassen von seltenen Mutationen und einer Kopienzahlvariation
|
|
US20160040229A1
(en)
|
2013-08-16 |
2016-02-11 |
Guardant Health, Inc. |
Systems and methods to detect rare mutations and copy number variation
|
|
US10876152B2
(en)
|
2012-09-04 |
2020-12-29 |
Guardant Health, Inc. |
Systems and methods to detect rare mutations and copy number variation
|
|
ES2660989T3
(es)
|
2013-12-28 |
2018-03-27 |
Guardant Health, Inc. |
Métodos y sistemas para detectar variantes genéticas
|
|
TWI895765B
(zh)
|
2014-07-18 |
2025-09-01 |
香港中文大學 |
Dna混合物中之組織甲基化模式分析
|
|
CA2956208C
(en)
*
|
2014-07-25 |
2025-07-08 |
University Of Washington |
METHODS FOR DETERMINING TISSUES AND/OR CELL TYPES RENDERING CELL-FREE DNA AND RELATED METHODS FOR DETERMINING A DISEASE OR DISORDER
|
|
US10364467B2
(en)
|
2015-01-13 |
2019-07-30 |
The Chinese University Of Hong Kong |
Using size and number aberrations in plasma DNA for detecting cancer
|
|
WO2016123698A1
(en)
*
|
2015-02-06 |
2016-08-11 |
Uti Limited Partnership |
Diagnostic assay for post-transplant assessment of potential rejection of donor organs
|
|
SG11201706529TA
(en)
|
2015-02-10 |
2017-09-28 |
Univ Hong Kong Chinese |
Detecting mutations for cancer screening and fetal analysis
|
|
US10453556B2
(en)
|
2015-07-23 |
2019-10-22 |
The Chinese University Of Hong Kong |
Analysis of fragmentation patterns of cell-free DNA
|
|
US20180327825A1
(en)
*
|
2015-11-09 |
2018-11-15 |
Progenity, Inc. |
Methods for determining the origin of dna molecules
|
|
CN117174167A
(zh)
|
2015-12-17 |
2023-12-05 |
夸登特健康公司 |
通过分析无细胞dna确定肿瘤基因拷贝数的方法
|
|
US11514289B1
(en)
|
2016-03-09 |
2022-11-29 |
Freenome Holdings, Inc. |
Generating machine learning models using genetic data
|
|
CA3030038A1
(en)
|
2016-07-06 |
2018-01-11 |
Guardant Health, Inc. |
Methods for fragmentome profiling of cell-free nucleic acids
|
|
CA3030430A1
(en)
|
2016-07-15 |
2018-01-18 |
The Regents Of The University Of California |
Methods of producing nucleic acid libraries
|
|
EP3494234B1
(en)
*
|
2016-08-05 |
2025-02-12 |
The Broad Institute, Inc. |
Methods for genome characterization
|
|
US9850523B1
(en)
|
2016-09-30 |
2017-12-26 |
Guardant Health, Inc. |
Methods for multi-resolution analysis of cell-free nucleic acids
|
|
KR20240155386A
(ko)
|
2016-09-30 |
2024-10-28 |
가던트 헬쓰, 인크. |
무세포 핵산의 다중-해상도 분석 방법
|
|
EP4656736A3
(en)
|
2016-10-12 |
2026-02-18 |
Bellwether Bio, Inc. |
Determining cell type origin of circulating cell-free dna with molecular counting
|
|
EP4209598A1
(en)
|
2016-10-19 |
2023-07-12 |
The Chinese University of Hong Kong |
Gestational age assessment by methylation and size profiling of maternal plasma dna
|
|
CA3041647A1
(en)
|
2016-10-24 |
2018-05-03 |
The Chinese University Of Hong Kong |
Methods and systems for tumor detection
|
|
CA3039685A1
(en)
|
2016-11-30 |
2018-06-07 |
The Chinese University Of Hong Kong |
Analysis of cell-free dna in urine and other samples
|
|
ES2983411T3
(es)
*
|
2016-12-13 |
2024-10-23 |
Bellwether Bio Inc |
Determinación de un estado fisiológico en un individuo analizando los puntos finales de fragmentos de ADN libre de células en una muestra biológica
|
|
WO2018119452A2
(en)
|
2016-12-22 |
2018-06-28 |
Guardant Health, Inc. |
Methods and systems for analyzing nucleic acid molecules
|
|
JP7429338B2
(ja)
|
2017-01-10 |
2024-02-08 |
ジュノー セラピューティクス インコーポレイテッド |
細胞療法および関連方法のエピジェネティック解析
|
|
ES2990117T3
(es)
|
2017-01-25 |
2024-11-28 |
Univ Hong Kong Chinese |
Aplicaciones de diagnóstico que utilizan fragmentos de ácido nucleico
|
|
EP3635138B1
(en)
|
2017-05-15 |
2024-07-03 |
Katholieke Universiteit Leuven |
Method for analysing cell-free nucleic acids
|
|
WO2018227202A1
(en)
|
2017-06-09 |
2018-12-13 |
Bellwether Bio, Inc. |
Determination of cancer type in a subject by probabilistic modeling of circulating nucleic acid fragment endpoints
|
|
WO2018227211A1
(en)
*
|
2017-06-09 |
2018-12-13 |
Bellwether Bio, Inc. |
Diagnosis of cancer or other physiological condition using circulating nucleic acid fragment sentinel endpoints
|
|
US10636512B2
(en)
|
2017-07-14 |
2020-04-28 |
Cofactor Genomics, Inc. |
Immuno-oncology applications using next generation sequencing
|
|
ES2959360T3
(es)
|
2017-07-26 |
2024-02-23 |
Univ Hong Kong Chinese |
Mejora del cribado del cáncer mediante ácidos nucleicos víricos acelulares
|
|
CN111213209A
(zh)
*
|
2017-10-12 |
2020-05-29 |
南托米克斯有限责任公司 |
根据生物体液的评估用癌症评分和反应预测
|
|
CN107545153B
(zh)
*
|
2017-10-25 |
2021-06-11 |
桂林电子科技大学 |
一种基于卷积神经网络的核小体分类预测方法
|
|
WO2019024341A1
(zh)
*
|
2017-11-27 |
2019-02-07 |
深圳华大生命科学研究院 |
一种体液游离dna的文库构建方法及其应用
|
|
CN108061794B
(zh)
*
|
2017-12-25 |
2020-03-27 |
苏州大学 |
一种无染色、无探针、无损检测细胞或类细胞结构微生物的类型及其周期的方法
|
|
US12590326B2
(en)
|
2018-01-10 |
2026-03-31 |
Guardant Health, Inc. |
Methods for fragmentome profiling of cell-free nucleic acids
|
|
EP3737774B1
(en)
|
2018-01-12 |
2024-12-25 |
Claret Bioscience, LLC |
Method for analyzing nucleic acid
|
|
EP3765638A2
(en)
*
|
2018-03-13 |
2021-01-20 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Diagnostic use of cell free dna chromatin immunoprecipitation
|
|
AU2019249422B2
(en)
|
2018-04-02 |
2025-09-25 |
Grail, Inc. |
Methylation markers and targeted methylation probe panels
|
|
WO2019209884A1
(en)
*
|
2018-04-23 |
2019-10-31 |
Grail, Inc. |
Methods and systems for screening for conditions
|
|
WO2019222657A1
(en)
*
|
2018-05-18 |
2019-11-21 |
The Johns Hopkins University |
Cell-free dna for assessing and/or treating cancer
|
|
JP2021526791A
(ja)
*
|
2018-06-04 |
2021-10-11 |
ガーダント ヘルス， インコーポレイテッド |
セルフリー核酸の細胞起源を決定するための方法およびシステム
|
|
AU2019280712B2
(en)
|
2018-06-06 |
2025-11-20 |
The Regents Of The University Of California |
Methods of producing nucleic acid libraries and compositions and kits for practicing same
|
|
CN108796056A
(zh)
*
|
2018-06-28 |
2018-11-13 |
元码基因科技（北京）股份有限公司 |
基于游离dna的目标基因捕获技术进行组织溯源的方法
|
|
WO2020006369A1
(en)
*
|
2018-06-29 |
2020-01-02 |
Guardant Health, Inc. |
Methods and systems for analysis of ctcf binding regions in cell-free dna
|
|
CN108913682A
(zh)
*
|
2018-07-05 |
2018-11-30 |
上海奥测医疗科技有限公司 |
一种制备cfDNA参考品的方法
|
|
CN112703254A
(zh)
*
|
2018-07-23 |
2021-04-23 |
香港中文大学 |
游离dna损伤分析及其临床应用
|
|
CN109448783B
(zh)
*
|
2018-08-07 |
2022-05-13 |
清华大学 |
一种染色质拓扑结构域边界的分析方法
|
|
IL281741B2
(en)
|
2018-09-27 |
2026-04-01 |
Grail Inc |
Methylation markers and a targeted methylation detection panel
|
|
EP3815005A4
(en)
*
|
2018-10-08 |
2022-03-30 |
Freenome Holdings, Inc. |
Transcription factor profiling
|
|
CN111172263A
(zh)
*
|
2018-11-12 |
2020-05-19 |
北京医院 |
一种应用于无创产前检测的参考物质及其制备方法
|
|
WO2020106987A1
(en)
*
|
2018-11-21 |
2020-05-28 |
Karius, Inc. |
Detection and prediction of infectious disease
|
|
WO2020131872A1
(en)
|
2018-12-17 |
2020-06-25 |
Guardant Health, Inc. |
Determination of a physiological condition with nucleic acid fragment endpoints
|
|
TW202536188A
(zh)
*
|
2018-12-19 |
2025-09-16 |
香港中文大學 |
游離dna末端特徵
|
|
US11657897B2
(en)
*
|
2018-12-31 |
2023-05-23 |
Nvidia Corporation |
Denoising ATAC-seq data with deep learning
|
|
KR102916051B1
(ko)
*
|
2019-01-24 |
2026-01-21 |
일루미나, 인코포레이티드 |
장기 건강 및 질환을 모니터링하기 위한 방법 및 시스템
|
|
CA3126428A1
(en)
|
2019-01-31 |
2020-08-06 |
Guardant Health, Inc. |
Compositions and methods for isolating cell-free dna
|
|
CN109841265B
(zh)
*
|
2019-02-22 |
2021-09-21 |
清华大学 |
使用片段化模式确定血浆游离核酸分子组织来源的方法和系统及应用
|
|
WO2020198942A1
(zh)
*
|
2019-03-29 |
2020-10-08 |
中国科学技术大学 |
基于峰聚类的单细胞染色质可及性测序数据分析方法和系统
|
|
US11939636B2
(en)
|
2019-05-31 |
2024-03-26 |
Guardant Health, Inc. |
Methods and systems for improving patient monitoring after surgery
|
|
CN110272985B
(zh)
*
|
2019-06-26 |
2021-08-17 |
广州市雄基生物信息技术有限公司 |
基于外周血血浆游离dna高通量测序技术的肿瘤筛查试剂盒及其系统与方法
|
|
CA3151538A1
(en)
|
2019-09-30 |
2021-04-08 |
Stefanie Ann Ward Mortimer |
Compositions and methods for analyzing cell-free dna in methylation partitioning assays
|
|
EP4715839A2
(en)
|
2019-10-11 |
2026-03-25 |
Guardant Health, Inc. |
Use of cell free bacterial nucleic acids for detection of cancer
|
|
CN110739027B
(zh)
*
|
2019-10-23 |
2023-04-18 |
深圳吉因加医学检验实验室 |
一种基于染色质区域覆盖深度的癌症组织定位方法及系统
|
|
CN114746560A
(zh)
|
2019-11-26 |
2022-07-12 |
夸登特健康公司 |
改进甲基化多核苷酸结合的方法、组合物和系统
|
|
EP4077721B1
(en)
*
|
2019-12-18 |
2025-03-05 |
The Chinese University Of Hong Kong |
Cell-free dna fragmentation and nucleases
|
|
EP4077715A4
(en)
*
|
2019-12-19 |
2024-09-25 |
Agency for Science, Technology and Research |
METHOD FOR ESTIMATING CIRCULATING TUMOR DNA BURDEN AND RELATED KITS AND METHODS
|
|
CN115151657A
(zh)
*
|
2019-12-20 |
2022-10-04 |
安可济控股有限公司 |
用于疾病检测的方法和系统
|
|
WO2021130356A1
(en)
|
2019-12-24 |
2021-07-01 |
Vib Vzw |
Disease detection in liquid biopsies
|
|
WO2021139716A1
(en)
*
|
2020-01-08 |
2021-07-15 |
The Chinese University Of Hong Kong |
Biterminal dna fragment types in cell-free samples and uses thereof
|
|
US20230053409A1
(en)
*
|
2020-01-09 |
2023-02-23 |
Seoul National University R&Db Foundation |
Atac-seq data normalization and method for utilizing same
|
|
CN111254194B
(zh)
*
|
2020-01-13 |
2021-09-07 |
东南大学 |
基于cfDNA的测序及数据分析的癌症相关生物标记及其在cfDNA样品分类中的应用
|
|
US12421558B2
(en)
*
|
2020-02-13 |
2025-09-23 |
10X Genomics, Inc. |
Systems and methods for joint interactive visualization of gene expression and DNA chromatin accessibility
|
|
US11475981B2
(en)
|
2020-02-18 |
2022-10-18 |
Tempus Labs, Inc. |
Methods and systems for dynamic variant thresholding in a liquid biopsy assay
|
|
US11211144B2
(en)
|
2020-02-18 |
2021-12-28 |
Tempus Labs, Inc. |
Methods and systems for refining copy number variation in a liquid biopsy assay
|
|
US11211147B2
(en)
|
2020-02-18 |
2021-12-28 |
Tempus Labs, Inc. |
Estimation of circulating tumor fraction using off-target reads of targeted-panel sequencing
|
|
CN113362897A
(zh)
*
|
2020-03-06 |
2021-09-07 |
福建和瑞基因科技有限公司 |
基于核小体分布特征的肿瘤标志物筛选方法及应用
|
|
CA3177127A1
(en)
|
2020-04-30 |
2021-11-04 |
Guardant Health, Inc. |
Methods for sequence determination using partitioned nucleic acids
|
|
IL298458A
(en)
*
|
2020-05-22 |
2023-01-01 |
Aqtual Inc |
Methods for characterizing cell-free nucleic acid fragments
|
|
CN111724860B
(zh)
*
|
2020-06-18 |
2021-03-16 |
深圳吉因加医学检验实验室 |
一种基于测序数据识别染色质开放区域的方法及装置
|
|
EP4179111B1
(en)
|
2020-07-10 |
2024-04-03 |
Guardant Health, Inc. |
Methods of detecting genomic rearrangements using cell free nucleic acids
|
|
WO2023282916A1
(en)
|
2021-07-09 |
2023-01-12 |
Guardant Health, Inc. |
Methods of detecting genomic rearrangements using cell free nucleic acids
|
|
CN111881418B
(zh)
*
|
2020-07-27 |
2023-05-16 |
中国农业科学院农业信息研究所 |
一种基于二分法的大豆气象产量预测方法及系统
|
|
WO2022026761A1
(en)
|
2020-07-30 |
2022-02-03 |
Guardant Health, Inc. |
Methods for isolating cell-free dna
|
|
CN112085067B
(zh)
*
|
2020-08-17 |
2022-07-12 |
浙江大学 |
一种高通量筛选dna损伤反应抑制剂的方法
|
|
WO2022046947A1
(en)
|
2020-08-25 |
2022-03-03 |
Guardant Health, Inc. |
Methods and systems for predicting an origin of a variant
|
|
EP4214329A4
(en)
*
|
2020-09-17 |
2024-12-04 |
The Regents of the University of Colorado, a body corporate |
Signatures in cell-free dna to detect disease, track treatment response, and inform treatment decisions
|
|
WO2022073012A1
(en)
|
2020-09-30 |
2022-04-07 |
Guardant Health, Inc. |
Compositions and methods for analyzing dna using partitioning and a methylation-dependent nuclease
|
|
WO2022087309A1
(en)
|
2020-10-23 |
2022-04-28 |
Guardant Health, Inc. |
Compositions and methods for analyzing dna using partitioning and base conversion
|
|
CA3199829A1
(en)
|
2020-11-30 |
2022-06-02 |
Guardant Health, Inc. |
Compositions and methods for enriching methylated polynucleotides
|
|
WO2022140629A1
(en)
|
2020-12-23 |
2022-06-30 |
Guardant Health, Inc. |
Methods and systems for analyzing methylated polynucleotides
|
|
TW202242145A
(zh)
*
|
2020-12-29 |
2022-11-01 |
比利時商比利時意志有限公司 |
核小體耗盡循環無細胞染色質片段之轉錄因子結合位點分析
|
|
WO2022173698A1
(en)
*
|
2021-02-09 |
2022-08-18 |
Illumina, Inc. |
Methods and systems for monitoring organ health and disease
|
|
EP4729633A2
(en)
|
2021-02-12 |
2026-04-22 |
Guardant Health, Inc. |
Methods for detecting nucleic acid variants
|
|
EP4314329A1
(en)
|
2021-03-25 |
2024-02-07 |
Guardant Health, Inc. |
Methods and compositions for quantifying immune cell dna
|
|
EP4320277A4
(en)
*
|
2021-04-08 |
2025-03-05 |
Delfi Diagnostics, Inc. |
CANCER DETECTION METHOD USING GENOME-WIDE CELL-FREE DNA FRAGMENTATION PROFILES
|
|
EP4320618A4
(en)
*
|
2021-04-08 |
2025-08-27 |
Fred Hutchinson Cancer Center |
METHOD FOR ANALYZING CELL-FREE DNA SEQUENCE DATA TO EXAMINE NUCLEOSOME PROTECTION AND CHROMATIN ACCESSIBILITY
|
|
EP4359562A1
(en)
|
2021-06-21 |
2024-05-01 |
Guardant Health, Inc. |
Methods and compositions for copy-number informed tissue-of-origin analysis
|
|
WO2023056065A1
(en)
|
2021-09-30 |
2023-04-06 |
Guardant Health, Inc. |
Compositions and methods for synthesis and use of probes targeting nucleic acid rearrangements
|
|
EP4504971A1
(en)
|
2022-04-07 |
2025-02-12 |
Guardant Health, Inc. |
Detecting the presence of a tumor based on methylation status of cell-free nucleic acid molecules
|
|
GB202205710D0
(en)
|
2022-04-19 |
2022-06-01 |
Univ Of Essex Enterprises Limited |
Cell-free DNA-based methods
|
|
EP4547857A1
(en)
|
2022-06-30 |
2025-05-07 |
Guardant Health, Inc. |
Enrichment of aberrantly methylated dna
|
|
WO2024056720A1
(en)
|
2022-09-13 |
2024-03-21 |
Medizinische Universität Graz |
Determining of health status and treatment monitoring with cell-free dna
|
|
WO2024073508A2
(en)
|
2022-09-27 |
2024-04-04 |
Guardant Health, Inc. |
Methods and compositions for quantifying immune cell dna
|
|
WO2024138180A2
(en)
|
2022-12-22 |
2024-06-27 |
Guardant Health, Inc. |
Integrated targeted and whole genome somatic and dna methylation sequencing workflows
|
|
EP4638781A2
(en)
|
2022-12-22 |
2025-10-29 |
Guardant Health, Inc. |
Methods involving methylation preserving amplification with error correction
|
|
EP4705522A1
(en)
|
2023-05-05 |
2026-03-11 |
Guardant Health, Inc. |
Cell-free dna blood-based test for cancer screening
|
|
WO2025029475A1
(en)
|
2023-07-28 |
2025-02-06 |
Guardant Health, Inc. |
Methods to enrich nucleotide variants by negative selection
|
|
WO2025038399A1
(en)
|
2023-08-11 |
2025-02-20 |
Guardant Health, Inc. |
Methylated enrichment methods for single-molecule genetic and epigenetic sequencing
|
|
CN117230165A
(zh)
*
|
2023-09-01 |
2023-12-15 |
深圳湾实验室 |
一种无创产前检测胎儿染色体拷贝数异常的优化方法
|
|
WO2025064706A1
(en)
|
2023-09-19 |
2025-03-27 |
Guardant Health, Inc. |
Detecting the presence of a tumor based on methylation status of cell-free nucleic acid molecules
|
|
WO2025076452A1
(en)
|
2023-10-06 |
2025-04-10 |
Guardant Health, Inc. |
Detecting tumor-related information based on methylation status of cell-free nucleic acid molecules
|
|
WO2025137389A2
(en)
|
2023-12-22 |
2025-06-26 |
Guardant Health, Inc. |
Methods for targeted single-molecule genetic and epigenetic sequencing
|
|
WO2025207817A1
(en)
|
2024-03-26 |
2025-10-02 |
Guardant Health, Inc. |
Method of determining the likelihood of a disease by combining biomarkers and imaging
|
|
WO2025208044A1
(en)
|
2024-03-28 |
2025-10-02 |
Guardant Health, Inc. |
Methods for cancer detection using molecular patterns
|
|
WO2025235889A1
(en)
|
2024-05-10 |
2025-11-13 |
Guardant Health, Inc. |
Methods involving multiplexed pooled pcr
|
|
WO2025250544A1
(en)
|
2024-05-31 |
2025-12-04 |
Guardant Health, Inc. |
Methods for analyzing chromatin architecture in tissue to boost detection of cancer associated signals in cell-free dna
|
|
WO2026015607A1
(en)
|
2024-07-09 |
2026-01-15 |
Guardant Health, Inc. |
Methods for partitioning hyper-, hypo-, and non-methylated dna
|
|
WO2026043718A1
(en)
|
2024-08-21 |
2026-02-26 |
Guardant Health, Inc. |
Methods to monitor patients treated with a cancer vaccine
|
|
WO2026060266A1
(en)
|
2024-09-13 |
2026-03-19 |
Guardant Health, Inc. |
Use of copy number variants for the identification of false positive tumor calls
|
|
WO2026073140A1
(en)
|
2024-09-27 |
2026-04-02 |
Guardant Health, Inc. |
Framework to identify genomic regions indicative of one or more biological conditions
|
|
WO2026076332A1
(en)
|
2024-10-03 |
2026-04-09 |
Guardant Health, Inc. |
Methods involving multi-modal tumor variant identification and tracking of tumor molecules
|
|
WO2026090570A1
(en)
|
2024-10-24 |
2026-04-30 |
Guardant Health, Inc. |
Detecting the presence of a biological condition based on a nucleic acid sample data analysis
|